EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies - Kiesewetter, B. (Department of Medicine i. Clinical Division of Oncology. Medical University of Vienna) ; Cherny, N. I. (Cancer Pain and Palliative Medicine Service. Department of Medical Oncology. Shaare Zedek Medical Center) ; Boissel, Nicolas (Diderot University Paris Faculty of Medicine) ; Cerisoli, F. (European Hematology Association) ; Dafni, U. (Frontier Science Foundation-Hellas) ; De Vries, Elisabeth G. E. (Department of Medical Oncology. University Medical Center Groningen) ; Ghia, Paolo (Universita Vita e Salute San Raffaele) ; Gökbuget, N. (Department of Hematology/Oncology. Goethe University) ; González-Calle, Verónica (Instituto de Investigación Biomédica de Salamanca) ; Huntly, B. (Cambridge Stem Cell Institute. Department of Haematology. University of Cambridge) ; Jäger, U. (Department of Medicine i. Clinical Division of Hematology and Hemostaseology. Medical University of Vienna) ; Latino, N. J. (Head Office. European Society for Medical Oncology) ; Douillard, Jean-Yves (Head Office. European Society for Medical Oncology) ; Malcovati, Luca (Department of Hematology Oncology. Fondazione IRCCS Policlinico San Matteo) ; Mateos, M. V. (Instituto de Investigación Biomédica de Salamanca) ; Ossenkoppele, G. J. (Amsterdam Universitair Medische Centra (Amsterdam, Països Baixos)) ; Porkka, K. (Helsinki University Hospital (Finlàndia)) ; Raderer, M. (Department of Medicine i. Clinical Division of Oncology. Medical University of Vienna) ; Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Scarfò, Lydia (Universita Vita e Salute San Raffaele) ; Wester, R. (Erasmus MC Cancer Institute (Rotterdam, Països Baixos)) ; Zygoura, P. (Frontier Science Foundation-Hellas) ; Sonneveld, P. (Department of Radiation Oncology. Erasmus MC Cancer Institute) ; Universitat Autònoma de Barcelona